In 2012, Svein Lien, CEO of Biotech Pharmacon (listed on the Oslo Stock Exchange) contacted Percorso Life Sciences (Dynal Biotech referral) to discuss a North American strategy for the company. At the time Biotech was involved in 3 business; wound healing, enzymes as a supplement, and molecular enzymes. We incorporated the entity in the U.S….
Hycult Biotech b.v. is an ongoing business and prior to 2009 used a U.S. based distribution partner for the previous 9+ years. Overtime Wim de Niet, Founder and Owner of Hycult began to identify behaviors by the distributor that did not align with their agreement and Hycult Biotech’s growth ambition. Dino DiCamillo and Wim de…
In 2015, Aaron Figg, Founder and Co-Owner of Solentim Ltd. contacted Percorso Life Sciences. Aaron was looking to identify a U.S. support partner to incorporate the company and provide back office support future U.S. based employees. Percorso and Solentim began its collaboration in early 2015 with an incorporation. We subsequently supported Solentim Inc. and Solentim…
Sepmag a world leader in development of magnetic separators. In 2014 Sepmag asked Percorso Life Sciences to lead its commercial effort in North America. Bryan Rittenberry, CBO at Percorso is the leading the commercial effort in North America. Bryan manages a network of agents, internal sales person, and oversees large scale production sales on behalf…